Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week , Randomized, Open-label Study of PCC1 in Healthy Volunteers for Skin Rejuvenation

NCT06641869 is registered in ClinicalTrials.gov with Express Rx, Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week , Randomized, Open-label Study of PCC1 in Healthy Volunteers for Skin Rejuvenation
Lead sponsor
Express Rx, Inc
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2022
Completion date
August 10, 2024
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin rejuvenation